Lucid Diagnostics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Lucid Diagnostics Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue4.352.430.380.500.00
Cost of Revenue7.105.983.610.590.00
Gross Profit-2.752.43-3.24-0.090.00
Operating Expenses
Research & Development5.997.2511.479.305.44
Selling, General & Administrative36.6235.6639.8218.042.84
Operating Expenses43.3050.9156.5527.338.28
Operating Income-46.05-48.48-56.17-27.42-8.28
Other Income/Expense
Interest Income0.320.420.090.000.00
Interest Expense0.03-0.42-0.010.660.00
Other Income/Expense0.230.030.000.000.00
Income
Income Before Tax-45.53-52.67-56.17-28.08-8.28
Income Tax Expense0.00-9.28-1.214.860.00
Net Income-45.53-52.67-56.17-28.08-8.28
Net Income - Continuous Operations-45.53-52.67-56.17-28.080.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-44.34-59.01-54.23-27.420.00
EBIT-45.50-61.53-56.16-27.42-8.28
Depreciation & Amortization0.692.021.650.000.00
Earnings Per Share
Basic EPS-1.00-1.00-2.00-2.00-1.00
Diluted EPS-1.00-1.00-2.00-2.00-1.00
Basic Shares Outstanding50.5041.7636.1718.6014.11
Diluted Shares Outstanding50.5041.7636.1718.6014.11